We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$50B
AUM Growth
+$1.17B
Cap. Flow
-$2.18B
Cap. Flow %
-4.37%
Top 10 Hldgs %
19.12%
Holding
2,694
New
394
Increased
928
Reduced
982
Closed
383

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$620M
2
SNOW icon
Snowflake
SNOW
+$450M
3
COR icon
Cencora
COR
+$403M
4
CVNA icon
Carvana
CVNA
+$320M
5
MSCI icon
MSCI
MSCI
+$318M

Sector Composition

Rank Sector Weight
1 Technology 25.56%
2 Financials 17.22%
3 Consumer Discretionary 12.2%
4 Healthcare 11.63%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
1601
Arrowhead Research
ARWR
$12.1B
$750K ﹤0.01%
21,734
-370,066
-94% -$8.14M
TPL icon
1602
Texas Pacific Land
TPL
$26.9B
$747K ﹤0.01%
+2,400
New +$756K
NATH icon
1603
Nathan's Famous
NATH
$403M
$742K ﹤0.01%
6,700
-800
-11% -$83.8K
SNBR
1604
DELISTED
Sleep Number
SNBR
$739K ﹤0.01%
+105,300
New +$922K
GRNT icon
1605
Granite Ridge Resources
GRNT
$621M
$738K ﹤0.01%
136,339
-93,661
-41% -$511K
ROL icon
1606
Rollins
ROL
$18.6B
$734K ﹤0.01%
+12,500
New +$711K
TWST icon
1607
Twist Bioscience
TWST
$5.32B
$732K ﹤0.01%
26,000
-6,900
-21% -$209K
NPWR icon
1608
NET Power
NPWR
$120M
$728K ﹤0.01%
241,900
+84,700
+54% +$226K
ASPN icon
1609
Aspen Aerogels
ASPN
$339M
$727K ﹤0.01%
104,500
+64,600
+162% +$455K
XENE icon
1610
Xenon Pharmaceuticals
XENE
$6.1B
$727K ﹤0.01%
18,100
-77,200
-81% -$2.72M
PRGS icon
1611
Progress Software
PRGS
$1.75B
$726K ﹤0.01%
16,525
+9,900
+149% +$456K
ABOS icon
1612
Acumen Pharmaceuticals
ABOS
$152M
$724K ﹤0.01%
423,600
-2,700
-0.6% -$3.74K
CVX icon
1613
Chevron
CVX
$382B
$723K ﹤0.01%
+4,658
New +$721K
LWAY icon
1614
Lifeway Foods
LWAY
$480M
$719K ﹤0.01%
+25,900
New +$729K
NNDM
1615
Nano Dimension
NNDM
$314M
$718K ﹤0.01%
457,100
+223,300
+96% +$326K
ARCT icon
1616
Arcturus Therapeutics
ARCT
$165M
$710K ﹤0.01%
38,500
-10,000
-21% -$161K
HOV icon
1617
Hovnanian Enterprises
HOV
$779M
$707K ﹤0.01%
5,500
-2,300
-29% -$307K
CHMI
1618
Cherry Hill Mortgage Investment Corp
CHMI
$82.3M
$703K ﹤0.01%
294,341
-14,300
-5% -$39.6K
KR icon
1619
Kroger
KR
$36.7B
$701K ﹤0.01%
10,400
-397,600
-97% -$27.7M
FTAI icon
1620
FTAI Aviation
FTAI
$20.2B
$701K ﹤0.01%
4,200
-431,700
-99% -$61.4M
FC icon
1621
Franklin Covey
FC
$239M
$701K ﹤0.01%
36,100
-10,400
-22% -$206K
LMB icon
1622
Limbach Holdings
LMB
$807M
$699K ﹤0.01%
7,200
-300
-4% -$36.1K
BFS
1623
Saul Centers
BFS
$858M
$698K ﹤0.01%
21,900
-9,100
-29% -$300K
NWG icon
1624
NatWest
NWG
$69.9B
$698K ﹤0.01%
+49,308
New +$696K
TRIP icon
1625
TripAdvisor
TRIP
$1.7B
$696K ﹤0.01%
+42,800
New +$747K

Similar funds

Two Sigma Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, Two Sigma Advisers held 2,694 positions worth $50B, up 2.4% from $48.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Two Sigma Advisers withdrew a net $2.18B in Q3 2025, closing 383 positions and reducing 982 holdings. Its most notable exit was Aon, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Two Sigma Advisers opened a new position in TJX Companies worth $209M.

  • Two Sigma Advisers's largest Q3 2025 buy was TJX Companies: 1,447,098 shares worth $209M.
  • Two Sigma Advisers added most to JPMorgan Chase in Q3 2025, an estimated $629M increase.
  • Two Sigma Advisers's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $620M.
  • Two Sigma Advisers fully exited Aon in Q3 2025, selling an estimated $258M.
  • Two Sigma Advisers's ten largest holdings make up 19% of its $50B portfolio in Q3 2025.
  • Two Sigma Advisers opened 394 new positions and closed 383 in Q3 2025.
  • Two Sigma Advisers's portfolio value rose 2.4% quarter-over-quarter to $50B.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.